Skip to main content

Rickets

Current Osteoporosis Reports volume 9, Article number: 291 (2011) Cite this article

Abstract

Rickets is disorder of a growing child arising from disorders that result in impaired apoptosis of hypertrophic cells and mineralization of the growth plate. Rickets due to nutritional causes remains an important global problem. The factors responsible for resurgence of rickets among dark-skinned infants living in developed countries include the following: residence in northern or southern latitudes, voluntary avoidance of exposure to solar ultraviolet B radiation, maternal vitamin D deficiency during pregnancy, and prolonged breastfeeding without provision of vitamin D supplements. Fibroblast growth factor 23 (FGF23), secreted by osteocytes, is an important regulator of serum phosphate and 1,25(OH)2D3 levels. Hypophosphatemic rickets resulting from increased synthesis or under-catabolism of FGF23 is reviewed.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Kronenberg HM. Developmental regulation of the growth plate. Nature. 2003;423:332–6.

    PubMed  CAS  Article  Google Scholar 

  2. Sabbagh Y, Carpenter TO, Demay MB. Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc Natl Acad Sci USA. 2005;102:9637–42.

    PubMed  CAS  Article  Google Scholar 

  3. •• Tiosano D & Hochberg Z Hypophosphatemia: the common denominator of all rickets. J Bone Miner Metab. 2009;27(4):392–401. This paper proposes a new classification for the differential diagnosis of rickets, which is based on the mechanisms leading to hypophosphatemia-high PTH activity, high FGF23 activity, or renal phosphaturia.

  4. Casella SJ, Reiner BJ, Chen TC, Holick MF. A possible defect in 25-hydroxylation as a cause of rickets. J Pediatr. 1994;124:929–32.

    PubMed  CAS  Article  Google Scholar 

  5. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA. 2004;101:7711–5.

    PubMed  CAS  Article  Google Scholar 

  6. Thacher TD, Fischer PR, Strand MA, Pettifor JM. Nutritional rickets around the world: causes and future directions. Ann Trop Paediatr. 2006;26:1–16.

    PubMed  Article  Google Scholar 

  7. Allgrove J. Is nutritional rickets returning? Archives of Disease in Childhood. 2004;89(8):699–701.

    PubMed  CAS  Article  Google Scholar 

  8. Beck-Nielsen SS, Brock-Jacobsen B, Gram J, Brixen K, Jensen TK. Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. European Journal of Endocrinology. 2009;160(3):491–7.

    PubMed  CAS  Article  Google Scholar 

  9. Ward LM, Gaboury I, Ladhani M, Zlotkin S. Vitamin D-deficiency rickets among children in Canada. Canadian Medical Association Journal. 2007;177(2):161–6.

    PubMed  Article  Google Scholar 

  10. McGillivray G, Skull SA, Davie G, et al. High prevalence of asymptomatic vitamin D and iron deficiency in East African immigrant children and adolescents living in a temperate climate. Archives of Disease in Childhood. 2007;92(12):1088–93.

    PubMed  Article  Google Scholar 

  11. Agarwal KS, Mughal MZ, Upadhyay P, Berry J, Mawer EB, J.M. P. The impact of atmospheric pollution on vitamin D status of infants and toddlers in Delhi, India. Arch Dis Chld. 2002; 87: 111–113.

  12. Das G, Crocombe S, McGrath M, Berry JL, Mughal MZ. Hypovitaminosis D among healthy adolescent girls attending an inner city school. Archives of Disease in Childhood. 2006;91(7):569–72.

    PubMed  CAS  Article  Google Scholar 

  13. van der Meer IM, Karamali NS, Boeke AJ. High prevalence of vitamin D deficiency in pregnant non-Western women in the Hague, Netherlands. Am J Clin Nutr. 2006;84(2):350–3.

    Google Scholar 

  14. Dijkstra SH, van Beek A, Janssen JW, de Vleeschouwer LH, Huysman WA, van den Akker EL. High prevalence of vitamin D deficiency in newborns of high-risk mothers. Arch Dis Chld Fetal Neonatal Ed. 2007

  15. Clemens TL, Adams JS, Henderson SL. Holick MF Increased skin pigmentation reduces the capacity of skin to synthesize vitamin D3. Lancet. 1982;1:74–6.

    PubMed  CAS  Article  Google Scholar 

  16. Crowe FL, Steur M, Allen NE, Appleby PN, Travis RC, Key TJ. Plasma concentrations of 25-hydroxyvitamin D in meat eaters, fish eaters, vegetarians and vegans: results from the EPIC-Oxford study. Public Health Nutr. 2011;14(2):340–6.

    PubMed  Article  Google Scholar 

  17. Clements M R, Johnson L, Fraser D R. A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature 1987. 32562–65.65.

  18. A Khadilkar, G Das, M Sayyad, N Sanwalka, D Bhandari, V Khadilkar, M Z Mughal. Letter. Low Calcium intake & Hypovitaminosis D in Adolescent Girls. Archives of Disease in Childhood. 2007;92 (11):1045.

  19. Mughal MZ, Salama H, Greenaway T, Laing I, Mawer EB. Florid rickets associated with prolonged breast feeding without vitamin D supplementation. BMJ. 1999;318:39–40.

    PubMed  CAS  Article  Google Scholar 

  20. Awumey EMK, Mitra DA, Hollis BW, Kumar R, Bell NH. Vitamin D metabolism is altered in Asian Indians in the South United States: a Clinical Research Center Study. J Clin Endocrinol Metab. 1998;83:169–73.

    PubMed  CAS  Article  Google Scholar 

  21. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376:180–8.

    PubMed  CAS  Article  Google Scholar 

  22. DeLucia MC, Mitnick ME, Carpenter TO. Nutritional rickets with normal circulating 25-hydroxyvitamin D: a call for reexamining the role of dietary calcium intake in North American infants. J Clin Endocrinol Metab. 2003;88(8):3539–45.

    PubMed  CAS  Article  Google Scholar 

  23. Gordon CM, Williams AL, Feldman HA, May J, Sinclair L, Vasquez A, et al. Treatment of hypovitaminosis D in infants and toddlers. J Clin Endocrinol Metab. 2008;93:2716–21.

    PubMed  CAS  Article  Google Scholar 

  24. Shah BR, Finberg L. Single-dose therapy for nutritional vitamin D-deficiency rickets: a preferred method. J Pediatr. 1994;125:487–90.

    PubMed  CAS  Article  Google Scholar 

  25. Dunnigan M G, Glekin B M, Henderson J B. et al Prevention of rickets in Asian children: assessment of the Glasgow campaign. BMJ 1985. 291(6490)239–242.242.

    Google Scholar 

  26. Hatun S, Ozkan B, Bereket A. Vitamin D deficiency and prevention: Turkish experience. Acta Paediatr. 2011;100(9):1195–9.

    PubMed  Article  Google Scholar 

  27. Malloy PJ, Feldman D. Genetic disorders and defects in vitamin D action. Endocrinol Metab Clin North Am. 2010;39(2):333–46.

    PubMed  CAS  Article  Google Scholar 

  28. •• Bergwitz C & Juppner H. 2010 Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annual Review of Medicine 61 91–104. Most insights gained into the regulation of phosphate homeostasis by these factors (PTH, vitamin D, and FGF23) are derived from human genetic disorders and genetically engineered mice, which are reviewed in this paper.

  29. Gattineni J, Bates C, Twombley K, et al. FGF-23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol. 2009;297:F282–91.

    PubMed  CAS  Article  Google Scholar 

  30. Kuro-O M. Overview of the FGF-23-Klotho axis. Pediatr Nephrol. 2010;25(4):583–90.

    PubMed  Article  Google Scholar 

  31. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, et al. Targeted ablation of FGF-23 demonstrates an essential physiological role of FGF-23 in phosphate and vitamin D metabolism. J Clin Invest. 2004;113:561–8.

    PubMed  CAS  Google Scholar 

  32. Perwad F, Zhang MY, Tenenhouse HS, Portale AA. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alphahydroxylase expression in vitro. Am J Physiol Renal Physiol. 2007;293:F1577–83.

    PubMed  CAS  Article  Google Scholar 

  33. Hyp_Consortium. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet. 1995;11:130–6.

    Article  Google Scholar 

  34. Liang G, Katz LD, Insogna KL, Carpenter TO, Macica CM. Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice. Calcif Tissue Int. 2009;85:235–46.

    PubMed  CAS  Article  Google Scholar 

  35. •• Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res. 2011 Jul;26(7):1381–8. This paper briefly reviews the clinical and pathophysiologic features XLH and offers a guide in response to the conference recommendation.

  36. Alon US, Levy-Olomucki R, Moore WV, Stubbs J, Liu S, Quarles LD. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clin J Am Soc Nephrol. 2008;3:658–64.

    PubMed  CAS  Article  Google Scholar 

  37. Yavropoulou MP, Kotsa K, Gotzamani Psarrakou A, Papazisi A, Tranga T, Ventis S, et al. Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review. Hormones (Athens). 2010;9(3):274–8.

    Google Scholar 

  38. Yang HM, Mao M, Yang F, Wan C. Recombinant growth hormone therapy for X-linked hypophosphatemia in children. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD004447. doi:10.1002/14651858.CD004447.

  39. Petje G, Meizer R, Radler C, Aigner N, Grill F. Deformity correction in children with hereditary hypophosphatemic rickets. Clin Orthop Relat Res. 2008;466(12):3078–85.

    PubMed  Article  Google Scholar 

  40. Souza MA, Jr Soares LA, Santos MA, Vaisbich MH. Dental abnormalities and oral health in patients with Hypophosphatemic rickets. Clinics (Sao Paulo). 2010;65(10):1023–6.

    Google Scholar 

  41. Imel EA, DiMeglio LA, Hui SL, et al. Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab. 2010;95:1846–50.

    PubMed  CAS  Article  Google Scholar 

  42. Aono Y, Yamazaki Y, Yasutake J, Kawata T, Hasegawa H, Urakawa I, et al. Therapeutic effects of Anti-FGF-23 antibodies in hypophosphatemic rickets/osteomalacia. J Bone Miner Res. 2009;24:1879–88.

    PubMed  CAS  Article  Google Scholar 

  43. Liu ES, Carpenter TO, Gundberg CM, Simpson CA, Insogna KL. Calcitonin Administration in X-Linked Hypophosphatemia. N Engl J Med. 2011;364(17):1678–80.

    PubMed  CAS  Article  Google Scholar 

  44. ADHR consortium Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF-23. Nat Genet. 2000;26:345–348.

    Google Scholar 

  45. Bai XY, Miao D, Goltzman D, Karaplis AC. The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem. 2003;278:9843–9.

    PubMed  CAS  Article  Google Scholar 

  46. Imel EA, Hui SL, Econs MJ. FGF-23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J Bone Miner Res. 2007;22(4):520–6.

    PubMed  CAS  Article  Google Scholar 

  47. Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet. 2006;38:1310–5.

    PubMed  CAS  Article  Google Scholar 

  48. Lorenz-Depiereux B, Bastepe M, Benet-Pages A, Amyere M, Wagenstaller J, Muller-Barth U, et al. DMP1 mutations in autosomal recessive hypophosphatemiaimplicate a bone matrix protein in the regulation of phosphate homeostasis. Nature Genet. 2006;38:1248–50.

    PubMed  CAS  Article  Google Scholar 

  49. Rutsch F, Ruf N, Vaingankar S, Toliat MR, Suk A, Höhne W, et al. Mutations in ENPP1 are associated with ‘idiopathic’ infantile arterial calcification. Nat Genet. 2003;34:379–81.

    PubMed  CAS  Article  Google Scholar 

  50. Rutsch F, Böyer P, Nitschke Y, et al. Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy. Circ Cardiovasc Genet. 2008;1:133–40.

    PubMed  CAS  Article  Google Scholar 

  51. Lorenz-Depiereux B, Schnabel D, Tiosano D, Hausler G, Strom TM. Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet. 2010;86:267–72.

    PubMed  CAS  Article  Google Scholar 

  52. Levy-Litan V, Hershkovitz E, Avizov L, Leventhal N, Bercovich D, Chalifa-Caspi V, et al. Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am J Hum Genet. 2010;86:273–8.

    PubMed  CAS  Article  Google Scholar 

  53. Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest. 2003;112(5):683–92.

    PubMed  CAS  Google Scholar 

  54. Chong WH, Molinolo AA, Chen CC, Collins MT. Tumor-induced osteomalacia. Endocr Relat Cancer. 2011;18:R53–77.

    PubMed  CAS  Article  Google Scholar 

  55. Jung GH, Kim JD, Cho Y, et al. A 9-month-old phosphaturic mesenchymal tumor mimicking the intractable rickets. J Pediatr Orthop B. 2010;19(1):127–32.

    PubMed  Article  Google Scholar 

  56. Hoffman WH, Jueppner HW, DeYoung BR, O'Dorisio MS, Given KS. Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome. American Journal of Medical Genetics Part A. 2005;134A:233–6.

    Article  Google Scholar 

  57. Tieder M, Modai D, Samuel R, Arie R, Halabe A, Bab I, et al. Hereditary hypophosphatemic rickets with hypercalciuria. N Engl J Med. 1985;312:611–7.

    PubMed  CAS  Article  Google Scholar 

  58. Bergwitz C, Roslin NM, Tieder M, Loredo-Osti JC, Bastepe M, Abu-Zahra H, et al. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet. 2006;78:179–92.

    PubMed  CAS  Article  Google Scholar 

  59. Lorenz-Depiereux B, Benet-Pages A, Eckstein G, Tenenbaum-Rakover Y, Wagenstaller J, Tiosano D, et al. Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet. 2006;78:193–201.

    PubMed  CAS  Article  Google Scholar 

  60. Ichikawa S, Sorenson AH, Imel EA, Friedman NE, Gertner JM, Econs MJ. Intronic deletions in the SLC34A3 gene cause hereditary hypophosphatemic rickets with hypercalciuria. J Clin Endocrinol Metab. 2006;91:4022–7.

    PubMed  CAS  Article  Google Scholar 

  61. Phulwani P, Bergwitz C, Jaureguiberry G, Rasoulpour M, Estrada E. Hereditary hypophosphatemic rickets with hypercalciuria and nephrolithiasis-identification of a novel SLC34A3/NaPi-IIc mutation. Am J Med Genet A. 2011;155A(3):626–33.

    PubMed  Google Scholar 

Download references

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Affiliations

  1. Department of Paediatric Endocrinology, Royal Manchester Children’s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Oxford Road, Manchester, M13 9WL, UK

    M. Zulf Mughal

Authors
  1. M. Zulf Mughal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Zulf Mughal.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mughal, M.Z. Rickets. Curr Osteoporos Rep 9, 291 (2011). https://doi.org/10.1007/s11914-011-0081-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11914-011-0081-0

Keywords

  • Calcium
  • FGF23
  • DMP1
  • Hypophosphatemic
  • ENPP1
  • PHEX
  • Phosphate
  • Rickets
  • Vitamin D
  • Vitamin D–dependent rickets
  • XLH
  • 25(OH)D
  • 1,25(OH)2D